AZN
Closed
Astrazeneca Plc Adr
71.46
+1.58 (+2.26%)
Last Update: 01 Jul 2025 23:14:00
Yesterday: 69.88
Day's Range: 70.04 - 72.01
Send
sign up or login to leave a comment!
When Written:
69.41
AstraZeneca PLC ADR (American Depositary Receipt) is a type of security that represents ownership in AstraZeneca, a British-Swedish multinational pharmaceutical company that develops and manufactures prescription drugs. ADRs are issued by a US bank that holds the underlying shares of the foreign company, and they trade on US stock exchanges like regular stocks.
AstraZeneca is a global leader in the pharmaceutical industry, with a focus on research and development of innovative medicines in areas such as oncology, cardiovascular, respiratory, and immunology. The company has a diverse portfolio of products and a strong pipeline of new drugs in development.
Investing in AstraZeneca ADRs allows US investors to gain exposure to the company's growth potential and dividend payments, while avoiding some of the regulatory and currency risks associated with investing directly in foreign stocks. However, ADRs may trade at a premium or discount to the underlying shares, and investors should carefully consider the risks and benefits before investing.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
AstraZeneca is a global leader in the pharmaceutical industry, with a focus on research and development of innovative medicines in areas such as oncology, cardiovascular, respiratory, and immunology. The company has a diverse portfolio of products and a strong pipeline of new drugs in development.
Investing in AstraZeneca ADRs allows US investors to gain exposure to the company's growth potential and dividend payments, while avoiding some of the regulatory and currency risks associated with investing directly in foreign stocks. However, ADRs may trade at a premium or discount to the underlying shares, and investors should carefully consider the risks and benefits before investing.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








